{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:35:04Z","timestamp":1773916504167,"version":"3.50.1"},"reference-count":42,"publisher":"Japanese Society of Toxicology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2012]]},"DOI":"10.2131\/jts.37.1165","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T22:55:43Z","timestamp":1354316143000},"page":"1165-1175","source":"Crossref","is-referenced-by-count":26,"title":["Behavioral and biochemical characterization of rats treated chronically with thioacetamide: proposal of an animal model for hepatic encephalopathy associated with cirrhosis"],"prefix":"10.2131","volume":"37","author":[{"given":"Hiroshi","family":"Kawai","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai International University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai International University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Kudo","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Mitsumoto","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Josai International University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Bassett, M.L., Mullen, K.D., Skolnick, P. and Jones, E.A. (1987): Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure. Gastroenterology, 93<\/b>, 1069-1077.","DOI":"10.1016\/0016-5085(87)90571-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bergeron, M., Reader, T.A., Layrargues, G.P. and Butterworth, R.F. (1989): Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem. Res., 14<\/b>, 853-859.","DOI":"10.1007\/BF00964814"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bernardini, P. and Fischer, J.E. (1982): Amino acid imbalance and hepatic encephalopathy. Annu. Rev. Nutr., 2<\/b>, 419-454.","DOI":"10.1146\/annurev.nu.02.070182.002223"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Butterworth, R.F., Norenberg, M.D., Felipo, V., Ferenci, P., Albrecht, J., Blei, A.T. and Members of the ISHEN Commission on Experimental Models of HE (2009): Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int., 29<\/b>, 783-788.","DOI":"10.1111\/j.1478-3231.2009.02034.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Cascino, A., Cangiano, C., Fiaccadori, F., Ghinelli, F., Merli, M., Pelosi, G., Riggio, O., Rossi Fanelli, F., Sacchini, D., Stortoni, M. and Capocaccia, L. (1982): Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy. Dig. Dis. Sci., 27<\/b>, 828-832.","DOI":"10.1007\/BF01391377"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Cryan, J.F., Markou, A. and Lucki, I. (2002): Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci., 23<\/b>, 238-245.","DOI":"10.1016\/S0165-6147(02)02017-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Dashti, H., Jeppsson, B., Hagerstrand, I., Hultberg, B., Srinivas, U., Abdulla, M. and Bengmark, S. (1989): Thioacetamide and carbon tetrachloride-induced liver cirrhosis. Eur. Surg. Res., 21<\/b>, 83-91.","DOI":"10.1159\/000129007"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Dere, E., Huston, J.P. and De Souza Silva, M.A. (2007): The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci. Biobehav. Rev., 31<\/b>, 673-704.","DOI":"10.1016\/j.neubiorev.2007.01.005"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Detke, M.J., Rickels, M. and Lucki, I. (1995): Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl), 121<\/b>, 66-72.","DOI":"10.1007\/BF02245592"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Dornelles, A., de Lima, M.N.M., Grazziotin, M., Presti-Torres, J., Garcia, V.A., Scalco, F.S., Roesler, R. and Schröder, N. (2007): Adrenergic enhancement of consolidation of object recognition memory. Neurobiol. Learn. Mem., 88<\/b>, 137-142.","DOI":"10.1016\/j.nlm.2007.01.005"},{"key":"11","unstructured":"Ennaceur, A. and Delacour, J. (1988): A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav. Brain Res., 31<\/b>, 47-59."},{"key":"12","unstructured":"Fanelli, R.F., Cangiano, C., Capocaccia, L., Cascino, A., Ceci, F., Muscaritoli, M. and Giunchi, G. (1986): Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences. Gut, 27 Suppl. 1<\/b>, 111-115."},{"key":"13","doi-asserted-by":"crossref","unstructured":"Ferenci, P., Lockwood, A., Mullen, K., Tarter, R., Weissenborn, K. and Blei, A.T. (2002): Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology, 35<\/b>, 716-721.","DOI":"10.1053\/jhep.2002.31250"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Fontana, L., Moreira, E., Isabel Torres, M., Isabel Fernandez, M., Rios, A., De Medina, F.S. and Gil, A. (1996): Serum amino acid changes in rats with thioacetamide-induced liver cirrhosis. Toxicology, 106<\/b>, 197-206.","DOI":"10.1016\/0300-483X(95)03177-H"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Jover, R., Rodrigo, R., Felipo, V., Insausti, R., Saez-Valero, J., Garcia-Ayllon, M.S., Suarez, I., Candela, A., Compan, A., Esteban, A., Cauli, O., Auso, E., Rodriguez, E., Gutierrez, A., Girona, E., Erceg, S., Berbel, P. and Perez-Mateo, M. (2006): Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis. Hepatology, 43<\/b>, 1257-1266.","DOI":"10.1002\/hep.21180"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Kawai, H., Kudo, N., Kawashima, Y. and Mitsumoto, A. (2009): Efficacy of urine bile acid as a non-invasive indicator of liver damage in rats. J. Toxicol. Sci., 34<\/b>, 27-38.","DOI":"10.2131\/jts.34.27"},{"key":"17","doi-asserted-by":"crossref","unstructured":"King, M.V., Sleight, A.J., Woolley, M.L., Topham, I.A., Marsden, C.A. and Fone, K.C.F. (2004): 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation--an effect sensitive to NMDA receptor antagonism. Neuropharmacology, 47<\/b>, 195-204.","DOI":"10.1016\/j.neuropharm.2004.03.012"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Lozeva-Thomas, V. (2004): Serotonin Brain Circuits with a Focus on Hepatic Encephalopathy. Metab. Brain Dis., 19<\/b>, 413-420.","DOI":"10.1023\/B:MEBR.0000043985.25055.b3"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Matkowskyj, K.A., Marrero, J.A., Carroll, R.E., Danilkovich, A.V., Green, R.M. and Benya, R.V. (1999): Azoxymethane-induced fulminant hepatic failure in C57BL\/6J mice: characterization of a new animal model. Am. J. Physiol., 277<\/b>, G455-62.","DOI":"10.1152\/ajpgi.1999.277.2.G455"},{"key":"20","unstructured":"Méndez, M., Méndez-López, M., López, L., Aller, M.Á., Árias, J., Cimadevilla, J.M. and Árias, J.L. (2008a): Spatial memory alterations in three models of hepatic encephalopathy. Behav. Brain Res., 188<\/b>, 32-40."},{"key":"21","unstructured":"Méndez, M., Méndez-López, M., López, L., Aller, M.Á., Árias, J. and Árias, J.L. (2008b): Working memory impairment and reduced hippocampal and prefrontal cortex c-Fos expression in a rat model of cirrhosis. Physiol. Behav., 95<\/b>, 302-307."},{"key":"22","unstructured":"Méndez, M., Méndez-López, M., López, L., Aller, M.Á., Árias, J. and Árias, J.L. (2009): Basal and learning task-related brain oxidative metabolism in cirrhotic rats. Brain Res. Bull., 78<\/b>, 195-201."},{"key":"23","unstructured":"Méndez, M., Méndez-López, M., López, L., Aller, M.Á., Árias, J. and Árias, J.L. (2011): Acetylcholinesterase activity in an experimental rat model of Type C hepatic encephalopathy. Acta Histochem., 113<\/b>, 358-362."},{"key":"24","doi-asserted-by":"crossref","unstructured":"Mortensen, P.B. (1992): The effect of oral-administered lactulose on colonic nitrogen metabolism and excretion. Hepatology, 16<\/b>, 1350-1356.","DOI":"10.1002\/hep.1840160608"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Mukherjee, S., Coque, L., Cao, J.L., Kumar, J., Chakravarty, S., Asaithamby, A., Graham, A., Gordon, E., Enwright, J.F., 3rd<\/sup>, Dileone, R.J., Birnbaum, S.G., Cooper, D.C. and McClung, C.A. (2010): Knockdown of Clock in the Ventral Tegmental Area Through RNA Interference Results in a Mixed State of Mania and Depression-Like Behavior. Biol. Psych., 68<\/b>, 503-511.","DOI":"10.1016\/j.biopsych.2010.04.031"},{"key":"26","unstructured":"Müller, A., Machnik, F., Zimmermann, T. and Schubert, H. (1988): Thioacetamide-induced cirrhosis-like liver lesions in rats--usefulness and reliability of this animal model. Exp. Pathol., 34<\/b>, 229-236."},{"key":"27","doi-asserted-by":"crossref","unstructured":"Nirogi, R., Abraham, R., Jayarajan, P., Medapati, R.B., Shanmuganathan, D., Kandikere, V., Irappanavar, S., Saralaya, R., Benade, V., Bhyrapuneni, G. and Muddana, N. (2012): Difference in the norepinephrine levels of experimental and non-experimental rats with age in the object recognition task. Brain Res., 1453<\/b>, 40-45.","DOI":"10.1016\/j.brainres.2012.03.013"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Noda, Y., Yamada, K., Furukawa, H. and Nabeshima, T. (1995): Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia. Br. J. Pharmacol., 116<\/b>, 2531-2537.","DOI":"10.1111\/j.1476-5381.1995.tb15106.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Noda, Y., Mamiya, T., Furukawa, H. and Nabeshima, T. (1997): Effects of antidepressants on phencyclidine-induced enhancement of immobility in a forced swimming test in mice. Eur. J. Pharmacol., 324<\/b>, 135-140.","DOI":"10.1016\/S0014-2999(97)00067-8"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Pitsikas, N. and Sakellaridis, N. (2005): The 5-HT2C receptor antagonist RO 60-0491 counteracts rats’ retention deficits in a recognition memory task. Brain Res., 1054<\/b>, 200-202.","DOI":"10.1016\/j.brainres.2005.06.057"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Porsolt, R.D., Anton, G., Blavet, N. and Jalfre, M. (1978): Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol., 47<\/b>, 379-391.","DOI":"10.1016\/0014-2999(78)90118-8"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Prasad, S., Dhiman, R.K., Duseja, A., Chawla, Y.K., Sharma, A. and Agarwal, R. (2007): Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology, 45<\/b>, 549-559.","DOI":"10.1002\/hep.21533"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Rahman, T.M., Selden, A.C. and Hodgson H.J.F. (2002): A novel model of acetaminophen-induced acute hepatic failure in rabbits. J. Surg. Res., 106<\/b>, 264-272.","DOI":"10.1006\/jsre.2002.6476"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Roybal, K., Theobold, D., Graham, A., DiNieri, J.A., Russo, S.J., Krishnan, V., Chakravarty, S., Peevey, J., Oehrlein, N., Birnbaum, S., Vitaterna, M.H., Orsulak, P., Takahashi, J.S., Nestler, E.J., Carlezon, W.A., Jr. and McClung, C.A. (2007). Mania-like behavior induced by disruption of CLOCK. Proc. Natl. Acad. Sci. USA, 104<\/b>, 6406-6411.","DOI":"10.1073\/pnas.0609625104"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Sato, M., Kakubari, M., Kawamura, M., Sugimoto, J., Matsumoto, K. and Ishii, T. (2000): The decrease in total collagen fibers in the liver by hepatocyte growth factor after formation of cirrhosis induced by thioacetamide. Biochem. Pharmacol., 59<\/b>, 681-690.","DOI":"10.1016\/S0006-2952(99)00359-7"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Schiapparelli, L., Simon, A.M., Del Rio, J. and Frechilla, D. (2006): Opposing effects of AMPA and 5-HT1A receptor blockade on passive avoidance and object recognition performance: correlation with AMPA receptor subunit expression in rat hippocampus. Neuropharmacology, 50<\/b>, 897-907.","DOI":"10.1016\/j.neuropharm.2006.02.005"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Scotti, M.A., Lee, G., Stevenson, S.A., Ostromecki, A.M., Wied, T.J., Kula, D.J., Gessay, G.M. and Gammie, S.C. (2011): Behavioral and pharmacological assessment of a potential new mouse model for mania. Physiol. Behav., 103<\/b>, 376-383.","DOI":"10.1016\/j.physbeh.2011.03.005"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Steindl, P.E., Coy, D.L., Finn, B., Zee, P.C. and Blei, A.T. (1996): A low-protein diet ameliorates disrupted diurnal locomotor activity in rats after portacaval anastomosis. Am. J. Physiol., 271<\/b>, G555-560.","DOI":"10.1152\/ajpgi.1996.271.4.G555"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Watanabe, M., Ozaki, T., Mushiroi, T., Ukai, Y., Ueda, F., Kimura, K., Katoh, M., Matsumoto, A., Kotani, E., Itoh, S., Yamaguchi, K. and Kyuki, K. (1997): Behavioral and electroencephalographic studies of beagles with an Eck’s fistula: suitability as a model of hepatic encephalopathy. Pharmacol. Biochem. Behav., 57<\/b>, 367-375.","DOI":"10.1016\/S0091-3057(96)00305-X"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Yamamoto, H. and Sugihara, N. (1987): Blood ammonia levels and hepatic encephalopathy induced by CCl4 in rats. Toxicol. Appl. Pharmacol., 91<\/b>, 461-468.","DOI":"10.1016\/0041-008X(87)90067-6"},{"key":"41","unstructured":"Yurdaydin, C., Herneth, A.M., Puspok, A., Steindl, P., Singer, E. and Ferenci, P. (1996). Modulation of hepatic encephalopathy in rats with thioacetamide-induced acute liver failure by serotonin antagonists. Eur. J. Gastroenterol. Hepatol., 8<\/b>, 667-671."},{"key":"42","doi-asserted-by":"crossref","unstructured":"Zimmermann, C., Ferenci, P., Pifl, C., Yurdaydin, C., Ebner, J., Lassmann, H., Roth, E. and Hortnagl, H. (1989). Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology, 9<\/b>, 594-601.","DOI":"10.1002\/hep.1840090414"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/37\/6\/37_1165\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:37:31Z","timestamp":1620963451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/37\/6\/37_1165\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.37.1165","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}